skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Journals@Ovid Complete remover Nome da Publicação: Value In Health remover Medline Complete remover MEDLINE Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata
PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata

Mauer, J ; Whichello, C ; Hauber, B ; Krucien, N ; Law, E ; Trapali, M ; Senna, M ; Tervonen, T

Value in health, 2022-12, Vol.25 (12), p.S406-S406 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity
Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity

Costa, M.G.S.D ; Santos, M.S ; Tura, B.R ; Goulart, M.C ; Cintra, M.A.C.T ; Senna, K.M.S

Value in health, 2014-11, Vol.17 (7), p.A482-A482 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System
HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System
Material Type:
Artigo 		Adicionar ao Meu Espaço

HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System

Almeida, P. ; Sebastião, M. ; Ferreira, P. ; Senna, T. ; Alexandre, R.F.

Value in health, 2023-06, Vol.26 (6), p.S274-S274 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective
EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective

Ferreira, P. ; Senna, T. ; Sebastião, M. ; Alexandre, R.F. ; Almeida, P.

Value in health, 2023-06, Vol.26 (6), p.S68-S69 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective
EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective

Senna, T. ; Alexandre, R.F. ; Almeida, P. ; Sebastião, M. ; Ferreira, P.

Value in health, 2023-06, Vol.26 (6), p.S87-S87 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System
EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System

Alexandre, R.F. ; Almeida, P. ; Sebastião, M. ; Ferreira, P. ; Senna, T.

Value in health, 2023-06, Vol.26 (6), p.S77-S77 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective
EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective

Sebastião, M. ; Ferreira, P. ; Senna, T. ; Alexandre, R.F. ; Almeida, P.

Value in health, 2023-06, Vol.26 (6), p.S156-S156 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY
PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY
Material Type:
Artigo 		Adicionar ao Meu Espaço

PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY

Senna, K. ; Santos, M. ; Parreira, V.

Value in health, 2018-10, Vol.21, p.S146-S146 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
Material Type:
Artigo 		Adicionar ao Meu Espaço

PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE

Costa, M.G. ; Santos, M. ; Senna, K.

Value in health, 2018-10, Vol.21, p.S439-S440 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE
PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE

Biz, A.N. ; Santos, M. ; Senna, K.

Value in health, 2018-10, Vol.21, p.S246-S246 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.